OPTIMOX study: FOLFOX 7/LV5FU2 compared to FOLFOX 4 in patients with advanced colorectal cancer-Reference-Cited by-同舟云学术

OPTIMOX study: FOLFOX 7/LV5FU2 compared to FOLFOX 4 in patients with advanced colorectal cancer

Published:2004-07-15 Issue:14_suppl Volume:22 Page:3525-3525
ISSN:0732-183X
Container-title:Journal of Clinical Oncology
language:en
Short-container-title:JCO

Author:

De Gramont A.¹,Cervantes A.¹,Andre T.¹,Figer A.¹,Lledo G.¹,Flesch M.¹,Mineur L.¹,Russ G.¹,Quinaux E.¹,Etienne P.-L.¹

Affiliation:

1. Hopital Saint Antoine, Paris, France; Hospital Clínico de Valencia, Valancia, Spain; Hopital Tenon, Paris, France; Tel Aviv Sourasky Medical Center, Tel Aviv, Israel; Clinique Saint Jean, Lyon, France; Hopital Drevon, Dijon, France; Clinique Sainte Catherine, Avignon, France; Landerskrankenhaus Salzburg, Paris, Austria; IDDI, Bruxelles, Belgium; Clinique Armoricaine, St Brieuc, France

Publisher

American Society of Clinical Oncology (ASCO)

Subject

Cancer Research,Oncology

Link

http://ascopubs.org/doi/pdfdirect/10.1200/jco.2004.22.90140.3525

Cited by 5 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Efficacy of different maintenance strategies for RAS wild-type colorectal cancer: A network meta-analysis;Digestive and Liver Disease;2024-02

2. Priorities in Colorectal Cancer Research: Recommendations From the Gastrointestinal Scientific Leadership Council of the Coalition of Cancer Cooperative Groups;Journal of Clinical Oncology;2007-06-01

3. Overall Survival of Patients With Advanced Colorectal Cancer Correlates With Availability of Fluorouracil, Irinotecan, and Oxaliplatin Regardless of Whether Doublet or Single-Agent Therapy Is Used First Line;Journal of Clinical Oncology;2005-12-20

4. Front-Line Therapy for Advanced Colorectal Cancer: Emphasis on Chemotherapy;Seminars in Oncology;2005-12

5. OncoSurge: A Strategy for Improving Resectability With Curative Intent in Metastatic Colorectal Cancer;Journal of Clinical Oncology;2005-10-01